Categories
Latest Industry Intelligence
The latest eBook by DDW is out now. This 28-page eBook, sponsored by Benchling, examines [...]
Discover the groundbreaking findings from a study on bispecific T cell engagers conducted by The [...]
Antibody-drug conjugates (ADCs) are biopharmaceutical products in which a monoclonal antibody (mAB) is linked to a small molecule drug with a stable linker1. According to NCBI, most of the ADCs [...]
Sales of branded anti-obesity drugs (AOB) could hit $44 billion in 2030 vs $2.5 billion in 2022, with just under 70% stemming from the US. The predictions come from analysts [...]
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report [...]
What are the global innovations in cell and gene therapy? What opportunities and challenges are emerging and can therapies get to market faster? DDW's Megan Thomas finds out. Skills gap [...]
The US market for medicines grew by 5% in 2022, reaching a total value of $429Bn on a net price basis. This was driven by a range of factors, including [...]
The first quarter of 2023 has seen deal flow continue for UK life science and biotech companies at all stages of development, new data from the UK BioIndustry Association and [...]
Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the [...]
Could India become an important centre of drug discovery innovation? Diana Spencer explores the evolution of the Hyderabad life sciences hub. India is traditionally known as ‘the pharmacy of the [...]
Drug Discovery World is the global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a [...]
Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us [...]
The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized [...]
Collaborative Research Leads To New Understanding Of Biomarkers By Dr Max Ryadnov and Professor Jason Crain A new collaborative research paper sheds light on the way antibodies distinguish between different [...]
Menu ≡ ╳ 
